Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 59Gastrointestinal 37Thoracic 31Genitourinary 22Gynecologic 20Other solid neoplasm 18Other hematologic neoplasm 17Tumor-Agnostic 16Lymphoid 14Other 12Dermatologic 12Head & Neck 7Other neoplasm 6Plasma cell 5CNS 3Sarcoma 2Myeloid 2Classical hematology 2

Conditions

Sarcoma 2

Interventions

Radiotherapy 220Doxorubicin 210Cyclophosphamide 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 80Irinotecan 79pembrolizumab 75Radiation 69Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Peripheral Blood Stem Cell Transplantation 57Surgical Procedures, Operative 56Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Educational Status × Sarcoma × Clear all
NCT05526417 2026-01-16

Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma

Mayo Clinic

Phase NA Recruiting
30 enrolled
Sarcoma

Sarcoma

NCT03258892 2022-09-28

Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy

Ohio State University Comprehensive Cancer Center

Phase NA Completed
64 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡